|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
AU631377B2
(en)
|
1988-08-25 |
1992-11-26 |
Liposome Company, Inc., The |
Affinity associated vaccine
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
KR920703114A
(ko)
|
1989-07-14 |
1992-12-17 |
원본미기재 |
접합체 백신을 위한 시토킨 및 호르몬 운반체
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
CA2138997C
(en)
|
1992-06-25 |
2003-06-03 |
Jean-Paul Prieels |
Vaccine composition containing adjuvants
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
NZ295998A
(en)
|
1994-10-24 |
1999-10-28 |
Ophidian Pharm Inc |
Neutralizing antitoxins against clostridium difficile and clostidium botulinum toxins
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
NZ312502A
(en)
|
1995-07-07 |
1999-03-29 |
Oravax Inc |
Clostridium difficile toxins as mucosal adjuvants
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
WO1998008540A1
(en)
|
1996-08-28 |
1998-03-05 |
Ophidian Pharmaceuticals, Inc. |
Multivalent vaccine for clostridium botulinum neurotoxin
|
|
DK1005368T3
(da)
|
1997-03-10 |
2010-01-04 |
Ottawa Hospital Res Inst |
Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
EP1000155A1
(en)
|
1997-06-20 |
2000-05-17 |
QUEEN MARY & WESTFIELD COLLEGE |
Immunogenic fragments of toxin a of clostridium difficile
|
|
AU1145699A
(en)
|
1997-09-05 |
1999-03-22 |
Smithkline Beecham Biologicals (Sa) |
Oil in water emulsions containing saponins
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
IL137809A0
(en)
|
1998-02-12 |
2001-10-31 |
American Cyanamid Co |
Pneumococcal and meningococcal vaccines formulated with interleukin-12
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
US20020009429A1
(en)
*
|
1999-01-29 |
2002-01-24 |
Galagen, Inc. |
Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
|
|
ATE459373T1
(de)
|
1999-03-19 |
2010-03-15 |
Glaxosmithkline Biolog Sa |
Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
|
|
US6733760B1
(en)
*
|
1999-04-09 |
2004-05-11 |
Techlab, Inc. |
Recombinant toxin A/toxin B vaccine against Clostridium difficile
|
|
JP2002542169A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅに対する、組換え毒素Ａ／毒素Ｂワクチン
|
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ， インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンａタンパク質キャリア
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
AU2001258107A1
(en)
*
|
2000-05-10 |
2001-11-20 |
Glycodesign Inc. |
Designing modulators for glycosyltransferases
|
|
CA2881568C
(en)
|
2000-10-27 |
2019-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from streptococcus groups a & b
|
|
WO2002079410A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Basf Plant Science Gmbh |
Glucan chain length domains
|
|
CA2492823A1
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
WO2004041857A2
(en)
|
2002-06-17 |
2004-05-21 |
Ballard Jimmy D |
Mutant of clostridium difficile toxin b and methods of use
|
|
US20040235139A1
(en)
*
|
2002-12-23 |
2004-11-25 |
Demain Arnold L. |
Clostridium difficile culture and toxin production methods
|
|
DK2270045T3
(en)
|
2004-02-06 |
2015-04-07 |
Univ Massachusetts |
ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINES AND APPLICATIONS THEREOF
|
|
WO2006071877A2
(en)
|
2004-12-27 |
2006-07-06 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally deliverable and anti-toxin antibodies and methods for making and using them
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
WO2007146139A2
(en)
|
2006-06-08 |
2007-12-21 |
Cornell Research Foundation, Inc. |
Codon-optimized dna molecules encoding the receptor binding domains of clostridium difficile toxins a and b
|
|
US20090311258A1
(en)
|
2006-08-02 |
2009-12-17 |
Johannes Gutenberg-Universitaet Mainz |
Medicament for lct poisoning
|
|
CA2693958A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Emergent Biosolutions, Inc. |
Chemically modified peptides with improved immunogenicity
|
|
US8524444B2
(en)
*
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
|
CA2733425A1
(en)
*
|
2008-08-06 |
2010-02-11 |
Emergent Product Development Uk Limited |
Vaccines against clostridium difficile and methods of use
|
|
AU2010215275B2
(en)
|
2009-02-20 |
2016-03-31 |
Micropharm Limited |
Antibodies to Clostridium difficile toxins
|
|
WO2011031568A2
(en)
|
2009-08-27 |
2011-03-17 |
Synaptic Research, Llc |
A NOVEL PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS
|
|
US10046040B2
(en)
|
2009-11-16 |
2018-08-14 |
University Of Maryland, Baltimore |
Multivalent live vector vaccine against Clostridium difficile-associated disease
|
|
US20120282274A1
(en)
|
2009-11-20 |
2012-11-08 |
Northshore University Health System Research Institute |
Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
|
|
WO2011068953A2
(en)
*
|
2009-12-02 |
2011-06-09 |
Tufts University |
Atoxic recombinant holotoxins of clostridium difficile as immunogens
|
|
GB0921288D0
(en)
|
2009-12-04 |
2010-01-20 |
Health Prot Agency |
Therapies for preventing or suppressing clostridium difficile infection
|
|
KR20130072201A
(ko)
|
2010-03-30 |
2013-07-01 |
피페넥스 인크. |
재조합 독소 단백질의 고수준 발현
|
|
US8986697B2
(en)
*
|
2010-04-15 |
2015-03-24 |
Progenics Pharmaceuticals, Inc. |
Antibodies for the treatment of Clostridium difficile-associated infection and disease
|
|
PL2753352T5
(pl)
|
2010-09-03 |
2022-10-17 |
Valneva Austria Gmbh |
Izolowany polipeptyd białek toksyny a i toksyny b z c. difficile i jego zastosowania
|
|
US8431361B2
(en)
|
2010-09-17 |
2013-04-30 |
Board Of Regents Of The University Of Oklahoma |
Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant Clostridium difficile toxin B
|
|
GB201016742D0
(en)
*
|
2010-10-05 |
2010-11-17 |
Health Prot Agency |
Clostridium difficile antigens
|
|
US8906635B2
(en)
|
2011-02-28 |
2014-12-09 |
Northshore University Healthsystem |
Methods of diagnosing Clostridium difficile infection
|
|
TWI815599B
(zh)
*
|
2011-04-22 |
2023-09-11 |
美商惠氏有限責任公司 |
與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法
|
|
HUE037126T2
(hu)
|
2011-05-27 |
2018-08-28 |
Glaxosmithkline Biologicals Sa |
Immunogén készítmény
|
|
AR087716A1
(es)
*
|
2011-08-31 |
2014-04-09 |
Valent Biosciences Corp |
Composiciones reguladoras del crecimiento de plantas, metodos de preparacion y usos de las mismas
|
|
AR089797A1
(es)
*
|
2012-01-27 |
2014-09-17 |
Merck Sharp & Dohme |
Vacunas contra clostridum difficile que comprenden toxinas recombinantes
|
|
GB201223342D0
(en)
*
|
2012-12-23 |
2013-02-06 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|